|
Index of reports
> Cases resulting in life threatening events (11)
> Cases with Hypoglycaemia (8)
Below is the selection of adverse event reports related to Glyburide that includes cases resulting in life threatening events where reactions include hypoglycaemia.
Adverse event in receiving Glyburide
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient:
Adverse reactions / side effects: Confusional State, Abdominal Pain, Agitation, Blood Creatine Phosphokinase Increased, Hypoglycaemia, Pain, Tachycardia, Coma, Pyrexia, Intentional Drug Misuse, Acidosis, Somnolence, Hyperhidrosis, Intentional Self-Injury, Overdose, Medication Error, Blood Electrolytes Abnormal, Dizziness, Coordination Abnormal, Vomiting, Nausea, Hyperglycaemia, Convulsion, Dysarthria, Syncope, Renal Failure, Diarrhoea, Suicide Attempt, Bradycardia, Hypertension
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Glyburide
Adverse event in 77 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-07-13
Patient: 77 year old male
Adverse reactions / side effects: Hypoglycaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Glyburide
Dosage: 10mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1998-09-14
End date: 2007-06-02
Rosiglitazone
Dosage: 8mg every day po
Administration route: Oral
Start date: 2000-10-16
End date: 2007-06-02
Adverse event in male receiving Glyburide
Reported by a pharmacist from United States on 2007-06-18
Patient: male, weighing 115.0 kg (253.0 pounds)
Adverse reactions / side effects: Syncope, Hypoglycaemia, Condition Aggravated, Cardiac Failure Congestive, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Glyburide
Dosage: 5mg bid (po)
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2006-02-01
End date: 2007-02-10
Glyburide
Dosage: 5mg bid (po)
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-02-10
End date: 2007-04-29
Other drugs received by patient: Carvedilol; Furosemide; Lisinopril; Clopidogrel; Simvastatin
Adverse event in 51 year old female receiving Glyburide
Reported by a physician from United States on 2007-06-15
Patient: 51 year old female, weighing 86.8 kg (191.0 pounds)
Adverse reactions / side effects: Hypoglycaemia, Altered State of Consciousness, Hyperhidrosis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Avandia
Dosage: 8 mg qd po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2004-02-19
Avandia
Dosage: 4 mg qd
Start date: 2006-07-07
Glyburide
Dosage: 5 mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2004-02-19
End date: 2007-01-07
Lantus
Dosage: 34 u qd sc
Indication: Diabetes Mellitus
Start date: 2006-09-07
Lantus
Dosage: 36 u qd sc
Indication: Diabetes Mellitus
Metformin Hydrochloride
Dosage: 2500 mg/day po
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2003-11-03
Other drugs received by patient: Ambien; Atorvastatin Calcium (Lipitor); Prevacid; Fosamax; Pregablin (Lyrica); Boniva; Insulin Glargine (Apidra); Simvastatin
Adverse event in 49 year old female receiving Glyburide
Reported by a individual with unspecified qualification on 2007-03-26
Patient: 49 year old female
Adverse reactions / side effects: Hypothermia, Hypoglycaemia, Circulatory Collapse, Lactic Acidosis, Loss of Consciousness, Renal Failure Acute
Adverse event resulted in: life threatening event
Suspect drug(s):
Glibenclamide
Indication: Diabetes Mellitus non-Insulin-Dependent
Glyburide
Indication: Diabetes Mellitus non-Insulin-Dependent
Hydrochlorothiazide
Indication: Hypertension
Hydrochlorothiazide
Indication: Hypertension
Losartan Postassium
Indication: Hypertension
Losartan Potassium
Indication: Hypertension
Metformin HCL
Indication: Diabetes Mellitus non-Insulin-Dependent
Metformin HCL
Indication: Diabetes Mellitus non-Insulin-Dependent
Other drugs received by patient: Alpha-Blocker; Alpha-Blocker
Adverse event in 80 year old male receiving Glyburide
Reported by a physician from Japan on 2007-02-28
Patient: 80 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Hypoglycaemia, Drug Interaction
Adverse event resulted in: life threatening event
Suspect drug(s):
Dibetos B
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1994-07-27
End date: 2006-11-21
Glyburide
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1988-08-05
End date: 2006-11-21
Omepral
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2006-11-18
End date: 2006-11-24
Other drugs received by patient: Omepral; Sucralfate
Adverse event in 80 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-02-05
Patient: 80 year old male, weighing 78.9 kg (173.6 pounds)
Adverse reactions / side effects: Hypoglycaemia, Mental Status Changes
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Glyburide
Adverse event in 81 year old male receiving Glyburide
Reported by a pharmacist from United States on 2007-01-16
Patient: 81 year old male, weighing 57.5 kg (126.5 pounds)
Adverse reactions / side effects: Hypoglycaemia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Glyburide
|
